Bisgaier Charles PhD
Insider CIK 1381030 · GEMP Chief Scientific Off. & Chair, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GEMP Gemphire Therapeutics Inc. | A Award | 2019-07-24 | 2019-07-26 | 100,000 | — | $0 | 1,348,914 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | A Award deriv | 2018-01-28 | 2018-01-30 | 48,000 | — | $0 | 48,000 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | M Exercise deriv | 2017-07-31 | 2017-08-02 | 4,474 | — | $0 | 0 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | M Exercise | 2017-07-31 | 2017-08-02 | 4,474 | $1.34 | $6.0K | 1,248,914 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | C Conversion deriv | 2016-08-10 | 2016-08-12 | 0 | — | $0 | 0 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | C Conversion deriv | 2016-08-10 | 2016-08-12 | 0 | — | $0 | 0 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | C Conversion deriv | 2016-08-10 | 2016-08-12 | 59,561 | — | $0 | 0 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | P Buy | 2016-08-10 | 2016-08-12 | 51,750 | $10.00 | $517.5K | 1,244,440 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | C Conversion | 2016-08-10 | 2016-08-12 | 59,561 | — | $0 | 59,561 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | C Conversion | 2016-08-10 | 2016-08-12 | 16,144 | $6.71 | $108.3K | 82,220 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | J Other | 2016-08-10 | 2016-08-12 | 6,515 | $6.71 | $43.7K | 66,076 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | C Conversion | 2016-08-10 | 2016-08-12 | 19,228 | $6.71 | $129.0K | 19,228 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | A Award deriv | 2016-08-04 | 2016-08-08 | 150,000 | — | $0 | 150,000 | SEC↗ |